Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Expanding the limits of personalized medicine with high-performance computing

25.07.2019

What should personalized, precision treatment of cancer look like in the future? We know that people are different, their tumors are different, and they respond differently to different therapies. Medical teams of the future might be able to create a "virtual twin" of a person and their tumor. Then, by tapping supercomputers, physician-led teams could simulate how tumor cells behave to test millions (or billions) of possible treatment combinations. Ultimately, the best combinations might offer clues towards a personalized, effective treatment plan.

Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik and Nicholson Collier, computational scientists at the U.S. Department of Energy's Argonne National Laboratory.


Jonathan Ozik ponders the results of the team's work on identifying, via simulation, the rules of cancer immunotherapy.

Credit: Argonne National Laboratory

The research team, which includes collaborators at Indiana University and the University of Vermont Medical Center, brought the power of high-performance computing to the thorny challenge of improving cancer immunotherapy.

The team tapped twin supercomputers at Argonne and the University of Chicago, finding that high-performance computing can yield clues in fighting cancer, as discussed in a June 7 article published in Molecular Systems Design and Engineering.

"With this new approach, researchers can use agent-based modeling in more scientifically robust ways." -- Nicholson Collier, computational scientist at Argonne and the University of Chicago

Standing up to cancer

Cancer immunotherapy is a promising treatment that realigns your immune system to reduce or eliminate cancer cells. The therapy, however, helps only 10 to 20 percent of patients -- partly because the way in which cancer cells and immune cells mingle is complex and poorly understood. Proven rules are scarce.

To begin uncovering the rules of immunotherapy, the team turned to a set of three tools:

  • Agent-based modeling, which predicted the behavior of individual "agents" - cancer and immune cells, in this case
  • Argonne's award-winning workflow technology to take full advantage of the supercomputers
  • A guiding framework to explore models and dynamically direct and track results

The trio operate in a hierarchy. The framework, developed by Ozik, Collier, Argonne colleagues, and Gary An, a surgeon and professor at the University of Vermont Medical Center, is called Extreme-scale Model Exploration with Swift (EMEWS). It oversees the agent-based model and the workflow system, the Swift/T parallel scripting language, developed at Argonne and the University of Chicago.

What is unique about this combination of tools? "We are helping more people in a variety of computational science fields to do large-scale experimentation with their models," said Ozik, who -- like Collier -- holds a joint appointment at the University of Chicago. "Building a model is fun. But without supercomputers, it is difficult to really understand the full potential of how models can behave." 

Working smarter, not harder

The team sought to find simulated scenarios in which:

  • No additional cancer cells grew
  • 90 percent of cancer cells died
  • 99 percent of cancer cells died

They found that no cancer cells grew in 19 percent of simulations, 9 in 10 cancer cells died in 6 percent of simulations, and 99 in 100 cancer cells died in about 2 percent of the simulations.

The team began with an agent-based model, built with the PhysiCell framework, designed by Indiana University's Paul Macklin to explore cancer and other diseases. They assigned each cancer and immune cell characteristics -- birth and death rates, for example -- that govern their behavior and then let them loose.

"We use agent-based modeling to address many problems," said Ozik. "But these models are often computationally intensive and produce a lot of random noise."

Exploring every possible scenario within the PhysiCell model would have been impractical. "You can't cover the entire model's possible behavior space," said Collier. So the team needed to work smarter, not harder.

The team relied on two approaches -- genetic algorithms and active learning, which are forms of machine learning-- to guide the PhysiCell model and find the parameters that best controlled or killed the simulated cancer cells.

Genetic algorithms seek those ideal parameters by simulating the model, say, 100 times and measuring the results. The model then repeats the process again and again using better-performing parameter values each time. "The process allows you to find the best set of parameters quickly, without having to run every single combination," said Collier.

Active learning is different. It also repeatedly simulates the model, but, as it does, it tries to discover regions of parameter values where it would be most advantageous to further explore in order to get a full picture of what works and what doesn't. In other words, "where you can sample to get the best bang for your buck," said Ozik.

Meanwhile, Argonne's EMEWS acted like a conductor, signaling the genetic and active learning algorithms at the right times and coordinating the large number of simulations on Argonne's Bebop cluster in its Laboratory Computing Resource Center, as well as on the University of Chicago's Beagle supercomputer.

Moving beyond medicine

The research team is applying similar approaches to challenges across different cancer types, including colon, breast and prostate cancer.

Argonne's EMEWS framework can offer insights in areas beyond medicine. Indeed, Ozik and Collier are currently using the system to explore the complexities of rare earth metals and their supply chains. "With this new approach, researchers can use agent-based modeling in more scientifically robust ways," said Collier.

###

The team also included Randy Heiland, a senior systems analyst and programmer at Indiana University. Argonne researchers were funded by the National Institutes of Health.

Video: Successful and unsuccessful cancer immunotherapy designs
Video: PhysiCell demo: immune cells attacking a heterogeneous tumor

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation's first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America's scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy's Office of Science.

The U.S. Department of Energy's Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.

Media Contact

Lynn Tefft Hoff
lhoff@anl.gov
630-252-1750

 @argonne

http://www.anl.gov 

Lynn Tefft Hoff | EurekAlert!
Further information:
https://www.anl.gov/article/expanding-the-limits-of-personalized-medicine-with-highperformance-computing
http://dx.doi.org/10.1039/C9ME00036D

More articles from Information Technology:

nachricht Spintronics: Faster data processing through ultrashort electric pulses
02.07.2020 | Martin-Luther-Universität Halle-Wittenberg

nachricht Multi-sensor system for the precise and efficient inspection of roads, railways and similar assets
01.07.2020 | Fraunhofer IPM

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electrons in the fast lane

Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.

Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....

Im Focus: The lightest electromagnetic shielding material in the world

Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.

Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...

Im Focus: Gentle wall contact – the right scenario for a fusion power plant

Quasi-continuous power exhaust developed as a wall-friendly method on ASDEX Upgrade

A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...

Im Focus: ILA Goes Digital – Automation & Production Technology for Adaptable Aircraft Production

Live event – July 1, 2020 - 11:00 to 11:45 (CET)
"Automation in Aerospace Industry @ Fraunhofer IFAM"

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM l Stade is presenting its forward-looking R&D portfolio for the first time at...

Im Focus: AI monitoring of laser welding processes - X-ray vision and eavesdropping ensure quality

With an X-ray experiment at the European Synchrotron ESRF in Grenoble (France), Empa researchers were able to demonstrate how well their real-time acoustic monitoring of laser weld seams works. With almost 90 percent reliability, they detected the formation of unwanted pores that impair the quality of weld seams. Thanks to a special evaluation method based on artificial intelligence (AI), the detection process is completed in just 70 milliseconds.

Laser welding is a process suitable for joining metals and thermoplastics. It has become particularly well established in highly automated production, for...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International conference QuApps shows status quo of quantum technology

02.07.2020 | Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

 
Latest News

Rising water temperatures could endanger the mating of many fish species

03.07.2020 | Life Sciences

Risk of infection with COVID-19 from singing: First results of aerosol study with the Bavarian Radio Chorus

03.07.2020 | Studies and Analyses

Efficient, Economical and Aesthetic: Researchers Build Electrodes from Leaves

03.07.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>